Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning.
暂无分享,去创建一个
Deidre Batchelar | Cynthia Araujo | Matt Schmid | J. Crook | F. Bachand | Juanita Crook | D. Batchelar | M. Gaztañaga | M. Schmid | C. Araujo | François Bachand | Miren Gaztañaga
[1] M. Eble,et al. Evaluation of source displacement and dose--volume changes after permanent prostate brachytherapy with stranded seeds. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] Luc Beaulieu,et al. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome. , 2007, International journal of radiation oncology, biology, physics.
[3] T. Krupski,et al. Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy. , 2001, The Journal of urology.
[4] Yvette Seppenwoolde,et al. HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] Deidre Batchelar,et al. A phantom study to assess accuracy of needle identification in real-time planning of ultrasound-guided high-dose-rate prostate implants. , 2013, Brachytherapy.
[6] Chris Beltran,et al. Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods. , 2008, International journal of radiation oncology, biology, physics.
[7] Ken Yoshida,et al. Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer. , 2010, Brachytherapy.
[8] Martin Ebert,et al. A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible. , 2010, International journal of radiation oncology, biology, physics.
[9] Patrick A Kupelian,et al. Image-guided radiotherapy for localized prostate cancer: treating a moving target. , 2008, Seminars in radiation oncology.
[10] Barry S Rosenstein,et al. Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results. , 2005, International journal of radiation oncology, biology, physics.
[11] D Andrew Loblaw,et al. Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy. , 2011, Brachytherapy.
[12] J. Pouliot,et al. Measurement of craniocaudal catheter displacement between fractions in computed tomography–based high dose rate brachytherapy of prostate cancer , 2007, Journal of applied clinical medical physics.
[13] J. Koziol,et al. Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors. , 2004, Brachytherapy.
[14] Y. Yamada,et al. Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT. , 2008, Brachytherapy.
[15] A. Zwinderman,et al. Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] D Baltas,et al. Evaluation of a TG-43 compliant analytical dosimetry model in clinical 192Ir HDR brachytherapy treatment planning and assessment of the significance of source position and catheter reconstruction uncertainties. , 2004, Physics in medicine and biology.
[17] H. Patrocinio,et al. An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound localizations. , 2007, International journal of radiation oncology, biology, physics.
[18] C C Ling,et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.
[19] J. Pouliot,et al. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. , 2004, International journal of radiation oncology, biology, physics.
[20] S Nag,et al. Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. , 1997, International journal of radiation oncology, biology, physics.
[21] Lei Dong,et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. , 2008, International journal of radiation oncology, biology, physics.
[22] Frank-André Siebert,et al. Imaging of implant needles for real-time HDR-brachytherapy prostate treatment using biplane ultrasound transducers. , 2009, Medical physics.